TELA Bio, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2017 | $-16.4M | $-16.5M | $114.0K | $197.0K |
| FY2018 | $-19.9M | $-20.0M | $62.0K | $216.0K |
| FY2019 | $-25.5M | $-25.7M | $197.0K | $457.0K |
| FY2020 | $-24.5M | $-24.6M | $167.0K | $2.1M |
| FY2021 | $-30.4M | $-31.1M | $627.0K | $3.7M |
| FY2022 | $-40.7M | $-41.6M | $872.0K | $4.0M |
| FY2023 | $-40.9M | $-41.5M | $611.0K | $5.0M |
| FY2024 | $-41.6M | $-42.6M | $989.0K | $4.4M |
| FY2025 | $-28.2M | $-28.7M | $448.0K | $3.8M |